This session will focus on the emerging role of digital therapeutics (DTx) in the treatment of substance use disorders (SUDs),…
On March 20, 2023, Aimed Alliance released a new fact sheet titled “Alternative Funding Programs: The Cost Sharing Program That…
On February 27, Aimed Alliance released a new Know Your Rights brochure for patients with Rare Endocrine Disorders. An endocrine…
For many individuals it can feel overwhelming being diagnosed with a new rare or chronic condition. This can be especially true…
On February 13, 2023, the Drug Enforcement Administration (DEA) responded to an inquiry by a North Carolina attorney regarding the…
Aimed Alliance, and twenty-eight other organizations asked the U.S. District Court for the District of Columbia to accept their amicus…
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…
On January 31, 2023, Aimed Alliance submitted a comment to the Centers for Medicaid and Medicare Services (CMS) and the…
On January 30, 2023, Aimed Alliance submitted a comment to the Centers for Medicaid and Medicare Services (CMS) and the…
Step therapy polices, also known as “fail first,” are a practice used by insurers and pharmacy benefit managers (PBMs) to…